Cargando…
Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma
OBJECTIVE: Currently, there is no standard adjuvant treatment protocol for localized uterine leiomyosarcoma (uLMS) as clinical trials to address this question have been retrospective, underpowered, or undermined by slow accrual rates. The aim of this study is to determine the benefit of adjuvant che...
Autores principales: | Chantharasamee, Jomjit, Wong, Karlton, Potivongsajarn, Pasathorn, Qorbani, Amir, Motamed, Neda, Brackert, Sandra, Cohen, Joshua, Chmielowski, Bartosz, Kalbasi, Anusha, Rao, Jianyu, Nelson, Scott, Singh, Arun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359871/ https://www.ncbi.nlm.nih.gov/pubmed/35307963 http://dx.doi.org/10.1002/cam4.4665 |
Ejemplares similares
-
Aggressive osteoblastoma with a secondary aneurysmal bone cyst treated with denosumab
por: Wong, Karlton, et al.
Publicado: (2021) -
Metastatic Melanoma of Uncertain Primary with 5-Year Durable Response after Conventional Therapy: A Case Report with Literature Review
por: Chantharasamee, Jomjit, et al.
Publicado: (2018) -
Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage
por: Patel, Dhara, et al.
Publicado: (2019) -
Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022) -
Microvessels Density in Uterine Leiomyosarcoma
por: Bobiński, Marcin, et al.
Publicado: (2015)